Could a multiple sclerosis drug help people with parkinsonism walk better?
NCT ID NCT07682428
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study looks at whether dalfampridine, a drug already used for walking problems in multiple sclerosis, can improve mobility in people with vascular parkinsonism or Parkinson-plus syndromes. Participants who do not respond well to standard levodopa treatment will receive dalfampridine or continue usual care for four weeks. Researchers will measure changes in walking speed, balance, and daily function to see if the drug helps.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dalfampridine
What this could lead to
If successful, this could point toward a new treatment option for mobility problems in people with vascular parkinsonism or related conditions.
What could go wrong
This is a small, early exploratory study. The results may not apply to everyone, and dalfampridine can cause side effects like seizures or dizziness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASCULAR PARKINSONISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tangdu Hospital, Fourth Military Medical University
Xi'an, Shaanxi, 710038, China